Sarah Cannon - HCA Research Institute

Nashville, Tennessee 37203

1 studies enrolling now · 1 studies all time

What they study most

B-cell Acute Lymphoblastic Leukemia

Studies at this site

• Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01) — Recruiting now